Navigation Links
Transdel Pharmaceuticals to Present at Rodman & Renshaw 10th Annual Global Healthcare Conference
Date:11/4/2008

LA JOLLA, Calif., Nov. 4 /PRNewswire-FirstCall/ -- Dr. Juliet Singh, President and Chief Executive Officer of Transdel Pharmaceuticals, Inc. (OTC Bulletin Board: TDLP, http://www.transdelpharma.com), will present at the Rodman & Renshaw Annual Global Healthcare Conference at the Palace Hotel in New York City. The Transdel presentation will be given in the Kennedy II room on the fourth floor of the hotel on Tuesday, November 11th at 2:25PM EST.

To listen to the audio web cast of the presentation, please visit the Investor Relations section of the Company's website at http://www.transdelpharma.com. An archive of the presentation will be available for replay for thirty days.

About Transdel Pharmaceuticals, Inc.

Transdel Pharmaceuticals, Inc. (OTCBB: TDLP) is a specialty pharmaceutical company developing non-invasive, topically delivered medications. The Company's innovative-patented proprietary Transdel(TM) cream formulation technology is designed to facilitate the effective penetration of drugs through the tough skin barrier to reach the target underlying tissues. In the case of Ketotransdel(TM), the Transdel(TM) cream allows the active ingredient ketoprofen to reach the target soft tissue and exert its well-known anti-inflammatory and analgesic effects. The Company is also investigating other drug candidates and treatments for transdermal delivery using the patented Transdel(TM) platform technology for products in pain management and other therapeutic areas. For more information, please visit http://www.transdelpharma.com.

Safe Harbor Statement

The statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncer
'/>"/>

SOURCE Transdel Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Transdel Pharmaceuticals Closes $4 Million Financing
2. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
3. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
6. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
7. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
8. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
9. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
10. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
11. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...xas, Nov. 5 SpineSmith Partners ha...to co-develop a unique scaffold that mimics the st...luation of several commercial products by SpineSmi...any believes the GenOsteo scaffold represents a si... unique and ideal environment for the delivery of ...
(Date:11/5/2009)... LASIK Surgery and vision correction expe... were actively involved at the recently concluded ...l Meeting in San Francisco, California. Dr. Stephe...nathan Davidorf, MD, Dr. Peter Rapoza, MD, Dr. Mic...ayne Bowman, MD, Dr. Edward Manche, MD, and Dr. Pa...
(Date:11/4/2009)... The Human Anthrax Vaccine Program must b... the feature film "A Call to Arms:2009 Editio...uot;Fatal Immunity: The Human Anthrax Vaccine Stor...resent danger of top secret government science tur... accountability to its victims. It is available f...
(Date:11/4/2009)...ROCKVILLE, Md., Nov. 4 Zyngenia, I...sed on next-generation antibody drug development, ... Series A funding from New Enterprise Associates (...irms. The capital will be used to create novel, mu...two or more biological targets with a single agent...
Breaking Biology Technology:SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 2Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 3Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 4Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 5Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 6Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 7Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 8Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 9Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 2Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 3Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 5Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 6Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 7Zyngenia, Inc. Raises $10 Million in Series A Funding 2Zyngenia, Inc. Raises $10 Million in Series A Funding 3Zyngenia, Inc. Raises $10 Million in Series A Funding 4
...tures, a venture,capital firm specializing in life...uang will join the firm as an Executive in Residen...erating experience, Mr. Huang will,work with Vivo,...resence in,Asia. "We are excited about James comi...ivo," said Frank Kung, Managing Partner of Vivo Ve...
...utics,Inc. (CTI) (Nasdaq and MTAX: CTIC) announced...R-NCI-EORTC Symposium show its bis-platinate drug,...ractory to currently,marketed platinum agents carb...s could enter human clinical trials in late 2008. ...f platinum-based,chemotherapy drugs with a potenti...
...rman . , Hydrogen fuel cells will power the auto...uffered from being insufficiently competitive. At ...by Peter Strasser has now developed a new class of...pacity of fuel cells. The active phase of the cata...h shell and a core made of an alloy of copper, cob...
Other Biology Technology:Vivo Ventures Expands Team with the Addition of James Huang as an Executive in Residence 2First New Class of Platinum-Based Chemotherapy Drug Candidates in 30 Years Demonstrate Ability to Kill Tumors Resistant to Currently Marketed Platinum Drugs 2First New Class of Platinum-Based Chemotherapy Drug Candidates in 30 Years Demonstrate Ability to Kill Tumors Resistant to Currently Marketed Platinum Drugs 3Platinum-rich shell, platinum-poor core 2
(Date:11/3/2009)... For more than 25 years, all attempts at culturin...ave been unsuccessfuluntil now. For the first time...uce beaded (nucleated) and non-beaded cultured pea...ientists from Florida Atlantic University,s Harbor...than two years of research and experimentation, Dr...
(Date:11/3/2009)...s much as 28 percent less likely to become pregnan...search that earned a Michigan State University pro...ra Luke, a researcher in the MSU College of Human ...d Reproductive Biology, focused on data of nearly ...y. , Luke,s findings, which also can be applied ...
(Date:11/3/2009)...ois at Chicago have received $1 million from the N...he relationship between "fat taxes" and food consu...for the two-year project was made available throug...09. , The study will link state tax rates associ... fat-laden foods and beverages (soda, candy, baked...
Breaking Biology News(10 mins):Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 2Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 3MSU researcher: Obesity significantly cuts odds of successful pregnancy 2UIC receives $1 million grant to study 'fat taxes,' diet, obesity 2Financing Available for Healthcare Equipment from DRE Medical Equipment 52870 1Financing Available for Healthcare Equipment from DRE Medical Equipment 52870 2Financing Available for Healthcare Equipment from DRE Medical Equipment 52870 3High calcium level in arteries may signal serious heart attack risk 52866 1High calcium level in arteries may signal serious heart attack risk 52866 2Norma McCorvey 28Formerly Roe of Roe vs Wade 29 Randall Terry and Over 30 Anti Abortion Activists From 7 States To Confront Nancy Pelosi Over Heal 52862 1
...once topped lists of places with the worst air pol...sions have improved the situation, tiny particles ...ic scientists from UC San Diego and six other inst...ver the city to precisely identify aerosols that m...s to the mix. , This forensic work will help to i...
...onn. Yale molecular and evolutionary biologists in...s produced the full genome sequence of Trichoplax...ganisms, providing a new insight into the evolutio...in the online edition of the journal Nature show...uclear genomes found in a multi-cellular creature,...
...Fla. --- Large flightless birds of the southern co...assowaries, South American rheas and the New Zeala... as once believed. , Instead, each species indivi...ors that did have the ability to fly, according to...lorida zoology professor Edward Braun. , The new ...
Other Biology News:Smoke smudges Mexico City's air, chemists identify sources 2Smoke smudges Mexico City's air, chemists identify sources 3Trichoplax genome sequenced -- 'rosetta stone' for understanding evolution 2New research challenges long-held assumptions of flightless bird evolution 2
Mouse Anti-Human gamma Glutamyl Transferase (gammaGT) Monoclonal Antibody, Unconjugated from AnaSpec
...to Cholesterol Oxidase Immunogen Cholesterol Oxi...ross-reacts with bacteria. Not yet tested in other...dases exist as both type I and type II oxidases an...ition, they are important as clinical reagents, po...
Goat Anti-XAGE1 Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-MDMA Monoclonal Antibody, Unconjugated, Clone 3G8 from ProSci, Inc
Biology Products: